Table 2.

Adverse Events

Variable	Placebo/placebo (n = 11)	Placebo/SER-287 weekly (n = 15)	Vancomycin/SER-287 weekly (n = 17)	Vancomycin/SER-287 daily (n = 15)
All AEs	7 (63.6)	9 (60.0)	14 (82.4)	8 (53.3)
Serious AEs	0	0	0	1 (6.7)
AEs of special interest	0	1 (6.7)	0	0
Severity of AEs
Mild	3 (27.3)	7 (46.7)	6 (35.3)	3 (20.0)
Moderate	4 (36.4)	2 (13.3)	8 (47.1)	5 (33.3)
Treatment-related AEs	1 (9.1)	4 (26.7)	7 (41.2)	2 (13.3)
AEs leading to discontinuation of study drug	0	1 (6.7)	2 (11.8)	0

NOTE. Values are n (%).

AE, adverse event.